Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You received radiation treatment (either to part of the brain or the whole brain and spine) for a brain tumour where radiotherapy was part of the main treatment plan
- Your child has one of these tumour types: ependymoma, medulloblastoma, malignant germ cell tumour, craniopharyngioma, or pinealoblastoma
- Your child was between 4 and 12 years old at the time of their radiation treatment
- Radiation treatment finished within approximately the last 2 years before joining the study
- Your child was treated with either standard radiation (photon therapy) or proton therapy
- Your child is able to see, hear (hearing aids are allowed), and communicate well enough to complete memory and thinking tests
- Your child and at least one parent/guardian speak French well enough to participate
- Your child is registered with the French social security system
- You and your child (where appropriate) have agreed to take part and signed a consent form in line with French law
Who may not be able to join:
- Your child has severe problems with balance and coordination (severe ataxia)
- Your child's tumour has come back (disease recurrence)
- Your child has certain medical implants or devices that make MRI scans unsafe — for example, a pacemaker, defibrillator, certain brain clips, or orthopaedic implants — or your child is very anxious in enclosed spaces (this applies specifically to participants at the Toulouse site)
- Your child is currently taking certain medications that affect mood, attention, or behaviour, such as methylphenidate (e.g. Ritalin) or antidepressants
- There are personal, family, location-based, or social circumstances that would make it difficult to attend appointments and follow the study as required
- Your child is under legal guardianship or has had their personal freedoms restricted in a legal sense
- Your child has a severe condition called posterior fossa syndrome with akinetic mutism (a serious complication affecting movement and speech — confirm with trial site)
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 05 31 15 54 43
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
A deficit of the declarative memory will be defined by a standard score of the Children' Memory Scale (CMS) ≤ 5
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.